Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker SHC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Michael B. Petras Jr. Executive Chairman, Director | SHC Sotera Health Company | Sale | 850,000 | $18.50 | $15.7M Sale | Form 4 ↗ |
| Aug 17, 2026 | Michael B. Petras Jr. Executive Chairman, Director | SHC Sotera Health Company | Sale | 294,515 | $18.50 | $5.4M Sale | Form 4 ↗ |
| Aug 7, 2026 | Michael P. Rutz President of Sterigenics | SHC Sotera Health Company | Sale | 150,000 | $18.84 | $2.8M Sale | Form 4 ↗ |
| May 13, 2026 | Warburg Pincus (Cayman) XI, L.P. Director, 10% owner | SHC Sotera Health Company | Sale | 19.10M | $15.17 | $289.8M Sale | Form 4 ↗ |
| May 13, 2026 | Warburg Pincus XI, L.P. Director, 10% owner | SHC Sotera Health Company | Sale | 19.10M | $15.17 | $289.8M Sale | Form 4 ↗ |
| May 13, 2026 | GTCR Fund Xi/C LP Director, 10% owner | SHC Sotera Health Company | Sale | 12.74M | $15.17 | $193.2M Sale | Form 4 ↗ |
| Mar 6, 2026 | Warburg Pincus Partners GP LLC Director, 10% owner | SHC Sotera Health Company | Sale | 15.00M | $15.27 | $229.1M Sale | Form 4 ↗ |
| Mar 6, 2026 | Warburg Pincus Partners II, L.P. Director, 10% owner | SHC Sotera Health Company | Sale | 15.00M | $15.27 | $229.1M Sale | Form 4 ↗ |
| Mar 6, 2026 | GTCR Co-Invest Xi LP Director, 10% owner | SHC Sotera Health Company | Sale | 10.00M | $15.27 | $152.7M Sale | Form 4 ↗ |
| Dec 8, 2025 | Michael B. Petras Jr. Chairman & CEO, Director | SHC Sotera Health Company | Sale | 39,243 | $16.45 | $645.5K Sale | Form 4 ↗ |
| Dec 8, 2025 | Michael B. Petras Jr. Chairman & CEO, Director | SHC Sotera Health Company | Sale | 394,861 | $16.45 | $6.5M Sale | Form 4 ↗ |
| Dec 8, 2025 | Michael B. Petras Jr. Chairman & CEO, Director | SHC Sotera Health Company | Sale | 315,896 | $16.45 | $5.2M Sale | Form 4 ↗ |
| Dec 3, 2025 | Warburg Pincus LLC Director, 10% owner | SHC Sotera Health Company | Sale | 9.72M | $16.33 | $158.7M Sale | Form 4 ↗ |
| Dec 3, 2025 | Warburg Pincus Partners GP LLC Director, 10% owner | SHC Sotera Health Company | Sale | 9.72M | $16.33 | $158.7M Sale | Form 4 ↗ |
| Dec 3, 2025 | GTCR Fund Xi/A LP Director, 10% owner | SHC Sotera Health Company | Sale | 6.48M | $16.33 | $105.8M Sale | Form 4 ↗ |
| Nov 10, 2025 | Warburg Pincus Private Equity XI-C, L.P. Director, 10% owner | SHC Sotera Health Company | Sale | 18.00M | $15.65 | $281.7M Sale | Form 4 ↗ |
| Nov 10, 2025 | Warburg Pincus Partners II, L.P. Director | SHC Sotera Health Company | Sale | 18.00M | $15.65 | $281.7M Sale | Form 4 ↗ |
| Nov 10, 2025 | GTCR Fund Xi/A LP Director, 10% owner | SHC Sotera Health Company | Sale | 12.00M | $15.65 | $187.8M Sale | Form 4 ↗ |
| Sep 5, 2025 | Warburg Pincus XI-C, LLC Director, 10% owner | SHC Sotera Health Company | Sale | 12.00M | $15.11 | $181.3M Sale | Form 4 ↗ |
| Sep 5, 2025 | Warburg Pincus & Co. Director, 10% owner | SHC Sotera Health Company | Sale | 12.00M | $15.11 | $181.3M Sale | Form 4 ↗ |
| Sep 5, 2025 | GTCR Investment Xi LLC Director, 10% owner | SHC Sotera Health Company | Sale | 8.00M | $15.11 | $120.9M Sale | Form 4 ↗ |
| Aug 22, 2025 | Michael P. Rutz President of Sterigenics | SHC Sotera Health Company | Sale | 126,611 | $16.38 | $2.1M Sale | Form 4 ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances